EDAP
EDAP TMS SA

1,635
Mkt Cap
$183.22M
Volume
38,368.00
52W High
$5.05
52W Low
$1.21
PE Ratio
-8.44
EDAP Fundamentals
Price
$4.90
Prev Close
$4.60
Open
$4.50
50D MA
$3.49
Beta
0.79
Avg. Volume
83,645.05
EPS (Annual)
-$0.5517
P/B
6.69
Rev/Employee
$223,718.07
$65.92
Loading...
Loading...
News
all
press releases
Edap Tms (NASDAQ:EDAP) Upgraded at Wall Street Zen
Wall Street Zen raised Edap Tms to a "hold" rating in a research report on Saturday...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Edap Tms (NASDAQ:EDAP) Stock Price Passes Above 200 Day Moving Average - Here's Why
Edap Tms (NASDAQ:EDAP) Stock Passes Above Two Hundred Day Moving Average - Here's Why...
MarketBeat·6d ago
News Placeholder
Edap Tms (NASDAQ:EDAP) Stock Passes Above Two Hundred Day Moving Average - Should You Sell?
Edap Tms (NASDAQ:EDAP) Stock Price Crosses Above 200 Day Moving Average - Here's Why...
MarketBeat·14d ago
News Placeholder
Edap Tms (NASDAQ:EDAP) Stock Crosses Above 200-Day Moving Average - Here's What Happened
Edap Tms (NASDAQ:EDAP) Stock Price Passes Above 200-Day Moving Average - What's Next...
MarketBeat·22d ago
News Placeholder
Edap Tms (NASDAQ:EDAP) Shares Cross Above 200 Day Moving Average - Time to Sell?
Edap Tms (NASDAQ:EDAP) Shares Cross Above Two Hundred Day Moving Average - Time to Sell...
MarketBeat·30d ago
News Placeholder
Edap Tms (NASDAQ:EDAP) Share Price Passes Above Two Hundred Day Moving Average - Here's Why
Edap Tms (NASDAQ:EDAP) Stock Price Crosses Above Two Hundred Day Moving Average - What's Next...
MarketBeat·1mo ago
News Placeholder
RBOT Enters Strategic Software Partnership to Streamline Development
Vicarious Surgical inks a software execution partnership to streamline development, cut costs and improve predictability.
Zacks·1mo ago
News Placeholder
Short Interest in Edap Tms S.A. (NASDAQ:EDAP) Increases By 163.4%
Edap Tms S.A. (NASDAQ:EDAP - Get Free Report) was the target of a significant increase in short interest during the month of December. As of December 15th, there was short interest totaling 93,243...
MarketBeat·2mo ago
News Placeholder
EW Wins FDA Approval for SAPIEN M3 as First Transseptal TMVR Therapy
Edwards Lifesciences wins FDA approval for SAPIEN M3, the first transseptal TMVR, expanding minimally invasive options for high-risk mitral regurgitation patients.
Zacks·2mo ago
News Placeholder
Edap Tms (NASDAQ:EDAP) Stock Price Passes Above 200-Day Moving Average - What's Next?
Edap Tms (NASDAQ:EDAP) Share Price Crosses Above Two Hundred Day Moving Average - Should You Sell...
MarketBeat·2mo ago
<
1
2
...
>

Latest EDAP News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.